STAT+: Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity

More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to tie executive compensation to vaccine equity in hopes of holding management “accountable” for contributing to a global health problem.

In a series of letters, the investors asked the heads of the board compensation committees at Pfizer (PFE), Johnson & Johnson (JNJ), Moderna (MRNA), and AstraZeneca (AZN) to adopt goals outlined recently by the World Health Organization to ensure 70% of the global population is vaccinated by the end of 2022.

Continue to STAT+ to read the full story…

STAT+: Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top